ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...
ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...
ANTI-NUTRITIONAL CONSTITUENT OF COLOCASIA ESCULENTA ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
a.-Amylase inhibitors could function as part of the defense mechanism in plants. In<br />
leguminous plants (Giri and Kachole, 1998; Melo et al., 1999) and cereals (Franco et al.,<br />
2000; Yamagata et al., 1998), the role of amylase inlnbitors as plant-defense proteins is<br />
pronounced and has received much focus (Gatehouse et al., 1986; Farmer and Ryan,<br />
1990). a-Amylases and proteinases are inactivated by these inlnbitors in the insect gut,<br />
thereby acting as insect anti-feedants. This interaction is believed to make plants less<br />
palatable. Indeed, it can even be lethal to insects. Thus, these inlnbitors present the plants<br />
with some selective advantages.<br />
Increasing natural defense mechanisms in plants can enhance agriculturaI activity and<br />
food safety by decreasing intensive use of pesticides (Huang et al., 1997; Chen et al.,<br />
1999). These inlnbitors, however, often show confined specificities: a given inhibitor<br />
may inhibit the major digestive enzymes ofone insect species, but not ofanother (Morton<br />
et al., 2000). This specificity has been widely investigated, with some inhibitors capable<br />
of acting against insect a-amylases or against mammalian enzymes only (Franco et aI.,<br />
2000). As a resuh, a-amylase inhibitors show potential for utilization in several fields,<br />
including protection ofcrops, obesity and treatment ofdiabetes (Tormo et aI., 2006).<br />
Diabetes mellitus is a metabolic disorder ofmultiple aetiology characterised by chronic<br />
hyperglycaemia with disturbance of carbohydrate, fat and protein metabolism resulting<br />
from defects in insulin secretion, insulin action or both (WHO, 1999). Glucose peaks<br />
occur after the intake of a meal in animals. a-Amylase inhibitors can reduce these peaks<br />
until the body is capable of processing the glucose. This is achieved by reducing the<br />
speed with which a-amylase can convert starch to simple sugars. Breuer (2003) held that<br />
this is especially important for diabetics who exhibit low insulin levels which hamper the<br />
prompt removal of extracellular glucose from the blood. Ali et al (2006) observed that<br />
reducing hyperglycaemia, using extracts of six selected Malaysian plants, after meals is<br />
one therapeutic approach which could be adopted in the treatement ofdiabetes.<br />
Clinical use of inhibitors of intraluminal a-amylase activity has appeal because, in<br />
theory, controlled reduction of starch digestion could influence carbohydrate uptake in<br />
123